Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Doobon is a South Korean specialty chemical company that operates a significant life science division focused on pharmaceutical excipients and active ingredients. Founded in 1991, the company has established itself as a leading global producer of hydrotalcite, a key ingredient in antacid medications and gastric mucosal protectants. Beyond its pharmaceutical offerings, Doobon manufactures a diverse range of polymer additives, flame retardants, and food additives. The company maintains rigorous quality standards, including GMP certification for its pharmaceutical-grade products, and serves a broad international clientele. Doobon's commitment to research and development allows it to provide high-performance chemical solutions across the healthcare and industrial sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Doobon.